AstraZeneca's Tagrisso slashes death risk in certain post-surgery lung cancer patients
reuters.com/business/healthcare-pharmaceuticals/astrazenecas-tagrisso-slashes-death-risk-certain-post-surgery-lung-cancer-2023-06-04/
Story Details
| Last Updated | Jun 05 23 |
| Total Articles | 5 |
News on this topic
British drug found to halve risk of dying from lung cancer: A drug from British pharmaceutical giant has been found to reduce the risk of dying from certain ...
metro.co.uk/2023/06/05/british-drug-found-to-halve-risk-of-dying-from-lung-cancer-18896809/
More articles on this subject
Previous
British drug found to halve risk of dying from lung cancer: A drug from British pharmaceutical giant has been found to reduce the risk of dying from certain ...
metro.co.uk/2023/06/05/british-drug-found-to-halve-risk-of-dying-from-lung-cancer-18896809/
AstraZeneca leaps after smashing first-quarter forecasts: AstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-beats-first-quarter-revenue-profit-estimates-2024-04-25/
AstraZeneca, Sanofi Bolt Higher On Quarterly Beats, But Bristol Myers Dives: AstraZeneca soundly topped analysts' views while Sanofi narrowed its losses.
investors.com/news/technology/astrazeneca-stock-bristol-myers-squibb-sanofi-earnings-q1-2024/
Corona vaccine damage: AstraZeneca must release information about the vaccine: A young woman has sued the pharmaceutical company AstraZeneca. She became ...
welt.de/gesundheit/article250931254/Corona-Impfschaden-AstraZeneca-muss-Informationen-zu-Impfstoff-freigeben.html
Quick Glance: Lawsuit after severe illness from Corona vaccination against Astrazeneca
- A woman from Upper Franconia achieves partial success against Astrazeneca in the lawsuit over serious health consequences after a Corona vaccination.
- Astrazeneca must provide comprehensive information on side effects of its vaccine.
- Plaintiff demands compensation and damages after severe illness from vaccination.
- Further lawsuits against Corona vaccine manufacturers may follow, while the woman's lawsuit continues.
AstraZeneca Shareholders Vote in Favor of £19 Million CEO Pay: AstraZeneca Plc shareholders backed a pay increase for Pascal Soriot, who is already the highest ...
bloomberg.com/news/articles/2024-04-11/astrazeneca-shareholders-vote-in-favor-of-19-million-ceo-pay
AstraZeneca’s Pascal Soriot ‘massively underpaid’ at £16.9mn, says top shareholder
ft.com/content/c7226781-b45b-4502-ba38-129dea5e960e
Is any CEO worth the £18.7m AstraZeneca wants to pay boss Pascal Soriot?: Pascal Soriot was already the highest-paid leader of a FTSE 100 company ...
independent.co.uk/independentpremium/business/astrazeneca-salary-pascal-soriot-b2527111.html
Paid articlePaid
AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand: AstraZeneca continued to see strong earnings boosted primarily by its oncology branch ...
euronews.com/business/2024/04/25/astrazeneca-reports-bumper-revenue-in-q1-2024-on-strong-drug-demand
AstraZeneca’s Profit Gains on Sales of Cancer Drugs: AstraZeneca Plc’s profit rose in the first quarter, buoyed by demand for its cancer blockbusters Imfinzi and ...
bloomberg.com/news/articles/2024-04-25/astrazeneca-s-profit-gains-on-sales-of-cancer-drugs
AstraZeneca chair: UK business needs a level playing field to compete: Double standards over pay do serious harm to our competitiveness in the war for talent
ft.com/content/86524f70-b121-4432-9403-94cd1c26f266
US FDA approves Daiichi, AstraZeneca drug for treatment of solid tumors: The U.S. Food and Drug Administration on Friday gave accelerated approval for the ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-daiichi-astrazeneca-drug-treatment-solid-tumors-2024-04-05/
Researchers discover new therapeutic target for non-small cell lung cancer: Non-small cell lung cancer accounts for nearly 85% of all lung cancer cases ...
medicalxpress.com/news/2024-04-therapeutic-small-cell-lung-cancer.html
Greifswalder AstraZeneca hero Greinacher receives award: During the Covid pandemic, his name was on everyone's lips - because Prof. Andreas Greinacher and his ...
ostsee-zeitung.de/lokales/vorpommern-greifswald/greifswald/greifswalder-astrazeneca-held-greinacher-wird-ausgezeichnet-WMG24FDT4ZBYHOZ5AURIBZPDN4.html
There's still plenty of shares to like on the poor old FTSE 100: City Voices: Taken together, London’s top flight mightn’t look so appealing ...
standard.co.uk/business/shares-ftse-100-london-stock-exchange-stocks-relx-astrazeneca-experian-b1151620.html
Elon Musk's attack, Jamie Dimon's warnings, AstraZeneca CEO's big pay: Leadership news roundup
qz.com/elon-musk-jamie-dimon-inflation-astrazeneca-ceo-pay-1851406684
Genomic deletions explain why some types of melanoma resist targeted therapies: Melanoma is the deadliest form of skin cancer. With global incidence rates rising ...
medicalxpress.com/news/2024-04-genomic-deletions-melanoma-resist-therapies.html
Takeover wave is rolling: Get to know three more hot candidates now: Discover 3 promising radiopharma stocks.
deraktionaer.de/artikel/pharma-biotech/uebernahmewelle-rollt-jetzt-drei-weitere-heisse-kandidaten-kennenlernen-20354959.html
AstraZeneca there: That's why these biotech stocks are now making hearts beat faster on Wall Street
boerse-online.de/nachrichten/aktien/astrazeneca-dabei-darum-lassen-diese-biotech-aktien-an-der-wall-street-jetzt-herzen-hoeher-schlagen--20354827.html
Study suggests liquid biopsy could detect and monitor aggressive small-cell lung cancer
medicalxpress.com/news/2024-04-liquid-biopsy-aggressive-small-cell.html
Iovance Biotherapeutics: Riding The Favorable Moment Could Bring Excellent Results
seekingalpha.com/article/4682837-iovance-biotherapeutics-riding-the-favorable-moment-could-bring-excellent-results
Paid articlePaid
Does the first court recognize corona vaccination damage?: Immediately after the vaccination she fell into a coma and part of her intestine had to be removed ...
bnn.de/nachrichten/politik/erkennt-das-erste-gericht-einen-corona-impfschaden-an
Paid articlePaid AstraZeneca's Imfinzi improves survival in late-stage lung cancer trial: AstraZeneca said on Friday its blockbuster cancer drug Imfinzi helped improve survival ...
reuters.com/business/healthcare-pharmaceuticals/astrazenecas-imfinzi-shows-promise-treating-aggressive-lung-cancer-2024-04-05/
Quick Glance: AstraZeneca's Imfinzi Shows Promise in Treating Aggressive Lung Cancer
- AstraZeneca announced that their cancer drug Imfinzi helps improve overall and progression-free survival in patients with limited-stage small cell lung cancer.
- In a late-stage trial, the drug demonstrated a statistically significant and clinically meaningful improvement in the dual primary goals of overall survival and progression-free survival.
- Small cell lung cancer is recognized for its high level of aggressiveness and rapid disease progression despite initial treatment with chemotherapy and radiotherapy.
- Imfinzi is part of the Anglo-Swedish drugmaker's key cancer portfolio and accounted for 23% of total group revenue last year.
In The Headlines: New Data on Targeted Systemic Treatment for Early-Stage Resectable NSCLC
twitter.com/i/broadcasts/1ZkKzjyorzXKv
Astra, Pfizer Boost China Bets Despite US Drive to Decouple: The chief executive officers of AstraZeneca Plc and Pfizer Inc. pledged to support expansion of ...
bloomberg.com/news/articles/2024-03-26/astra-pfizer-double-down-on-china-investment-amid-us-tensions
Paid articlePaid
Continued Benefit, More Toxicity With First-Line Osimertinib Plus Chemo in NCSLC: Patients with advanced EGFR-mutated NSCLC who were given osimertinib plus ...
medscape.com/viewarticle/continued-benefit-more-toxicity-first-line-osimertinib-plus-2024a10005n1
Novocure's device shown to slow cancer progression in the brain in trial: Novocure's therapy met the main goal of a late-stage trial of slowing the progression ...
reuters.com/business/healthcare-pharmaceuticals/novocures-lung-cancer-therapy-succeeds-late-stage-trial-2024-03-27/
Astra to Buy Fusion Pharma for Up to $2.4 Billion: AstraZeneca Plc agreed to buy Fusion Pharmaceuticals Inc. for as much as $2.4 billion as European drugmakers ...
bloomberg.com/news/articles/2024-03-19/astrazeneca-to-buy-fusion-pharma-for-up-to-2-4-billion
Lung cancer vaccine being developed by UK researchers : Using technology similar to that used to create the AstraZeneca Covid-19 vaccine ...
itv.com/news/2024-03-22/lung-cancer-vaccine-being-developed-by-uk-researchers
AstraZeneca to buy Amolyt Pharma for $1.05 bln to boost rare-disease portfolio: Drugmaker AstraZeneca said on Thursday it would acquire endocrine ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-buy-amolyt-pharma-105-bln-boost-rare-diseases-portfolio-2024-03-14/
Big Pharma is “coming to the table” on price negotiations as it loses in court: Negotiating prices is not a "gun to the head," judge rules.
arstechnica.com/science/2024/03/big-pharma-is-coming-to-the-table-on-price-negotiations-as-it-loses-in-court/
Astra-Sanofi's RSV therapy 90% effective against infant hospitalizations, CDC study shows
reuters.com/business/healthcare-pharmaceuticals/astra-sanofis-rsv-therapy-highly-effective-against-infant-hospitalizations-cdc-2024-03-07/
Quick Glance: Study: Astra-Sanofi RSV Therapy 90% Effective in Protecting Infants from Hospitalizations
- A CDC study shows AstraZeneca and Sanofi's antibody therapy is 90% effective.
- The therapy, known as Beyfortus, received U.S. health regulator approval in July 2023.
- Early CDC estimates support the therapy's recommendation for vulnerable infants.
- Effectiveness of the therapy will continue to be monitored throughout the season.
AstraZeneca to invest 650 million pounds in UK to boost 'pandemic preparedness': AstraZeneca plans to invest 650 million pounds ($826.80 million) in Britain to ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-invest-650-million-pounds-uk-boost-pandemic-preparedness-2024-03-06/
Biotech Rally Gets $100 Billion M&A Lift With More Deals to Come: A rash of dealmaking helped reverse the declining fortunes of biotech stocks over the last five ...
bloomberg.com/news/articles/2024-03-14/biotech-rally-gets-100-billion-m-a-lift-with-more-deals-to-come
Paid articlePaid US judge upholds Medicare drug price negotiation program: A federal judge in Delaware on Friday upheld a law that requires some drugmakers to negotiate prices ...
reuters.com/legal/second-judge-upholds-medicare-drug-price-negotiation-program-2024-03-01/
Why Is London Stock Exchange in Trouble? Low Trading Volume and an IPO Drought: Since Prime Minister Margaret Thatcher unleashed a wave of privatizations in the ...
bloomberg.com/news/articles/2024-02-28/why-is-london-stock-exchange-in-trouble-low-trading-volume-and-an-ipo-drought
Osimertinib Plus Chemo Approved for EGFR-mutated NSCLC: With the new approval, patients now have the option of combination treatment or osimertinib monotherapy.
medscape.com/viewarticle/osimertinib-plus-chemo-approved-egfr-mutated-nsclc-2024a10003j5
Paid articlePaid
Liverpool: New £450m vaccine manufacturing hub announced in Budget: The plans will strengthen the UK's resilience for future health emergencies, Jeremy Hunt says
bbc.com/news/uk-england-merseyside-68493663
AstraZeneca CEO Pascal Soriot’s £17m pay package under fire: Governance thinktank asks whether he has earned a hundred times that of many of his employees
theguardian.com/business/2024/feb/20/astrazeneca-ceo-pascal-soriot-17m-pay-makes-him-one-of-best-paid-ftse-100-bosses
Widow sues AstraZeneca after husband's Covid-19 vaccine death: Kam Miller's husband Neil, 50, suffered a rare fatal reaction to his Covid vaccination shot.
bbc.com/news/uk-england-leicestershire-68285232
U.S. FDA approves AstraZeneca's Tagrisso-chemo combo: A combination of AstraZeneca's blockbuster cancer drug Tagrisso with chemotherapy to treat a type of lung ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-astrazenecas-tagrisso-chemo-combo-2024-02-17/
Covid vaccines linked to rare heart and brain disorders, says vaccine study: A recent peer-reviewed study has revealed rare occurrences of heart, brain ...
iol.co.za/news/world/covid-vaccines-linked-to-rare-heart-and-brain-disorders-says-vaccine-study-b3ab0442-ee5d-45c3-bc84-7fd99049d9a4
Judge denies AstraZeneca’s lawsuit against Medicare negotiation: A judge on Friday granted the federal government’s request for summary judgment against ...
thehill.com/homenews/4501552-judge-denies-astrazenecas-lawsuit-against-medicare-negotiation/
MacroGenics: Positive Safety Update Leads To Two Major Inflection Points In 2024: Read about MacroGenics' positive safety update from phase 2 TAMARACK study ...
seekingalpha.com/article/4682276-macrogenics-positive-safety-update-leads-to-two-major-inflection-points-in-2024
Paid articlePaid
99 million vaccinated people analyzed: Most common side effects of the corona vaccination
focus.de/gesundheit/news/99-millionen-probanden-grosse-studie-identifiziert-die-haeufigsten-nebenwirkungen-der-corona-impfung_id_259695927.html
Bristol Myers Squibb to lay off hundreds of workers following its $4.8B merger with this San Diego biotech
sandiegouniontribune.com/business/story/2024-04-03/bristol-myers-squibb-to-lay-off-hundreds-of-workers-following-its-4-8b-merger-with-this-san-diego-biotech
Bamberg: Trial against Astrazeneca - woman loses part of her intestine after corona vaccination
infranken.de/lk/bamberg/bamberg-prozess-gegen-astrazeneca-frau-verliert-nach-corona-impfung-teil-des-darms-art-5713330
AstraZeneca Drug Slows Progression in Advanced Lung Cancer: AstraZeneca Plc shares rose after trial data showed Tagrisso slowed disease progression in patients ...
trib.al/oOwrPah
RKI doubted AstraZeneca for months: “Less perfect”, “not a sure-fire success”, “2-class vaccination”
fr.de/politik/rki-protokolle-robert-koch-institut-corona-coronavirus-impfung-astrazeneca-zr-92921607.html
Is Consolidation Osimertinib Superior to Durvalumab in EGFR-Mutated Non–Small Cell Lung Cancer?
medscape.com/viewarticle/consolidation-osimertinib-superior-durvalumab-egfr-mutated-2024a10002qs
Paid articlePaid In the Headlines: New Data on Targeted Systemic Treatment for Early-Stage Resectable NSCLC
medscape.org/viewarticle/1000383
FTSE 100 listless as losses in AstraZeneca offset earnings bump: The UK's FTSE 100 was relatively unchanged following an initial rise on Thursday ...
reuters.com/world/uk/london-equities-tracks-global-markets-higher-astrazeneca-falls-2024-02-22/
EVs plus other letters, March 26: ‘It’s ridiculous for the public to subsidize these expensive vehicles for people who can afford them’
theglobeandmail.com/opinion/letters/article-evs-electric-vehicle-subsidies-cost/
Paid articlePaid AstraZeneca CEO Soriot Says Market Access Is Turning Pharma Off the UK: Hurdles in bringing drugs to market in the UK is putting pharmaceutical companies off ...
bloomberg.com/news/articles/2024-02-08/astra-ceo-soriot-says-market-access-is-turning-pharma-off-the-uk
Paid articlePaid
Blood test detects Stage 4 lung cancer for Kat Robinson: A woman from Dorset was alerted to her stage 4 lung cancer following her involvement in a blood test ...
bournemouthecho.co.uk/news/24204962.blood-test-detects-stage-4-lung-cancer-kat-robinson/
Merck combination treatment for lung cancer fails late-stage study: Merck said on Thursday a combination of two of its cancer drugs failed to meet the main goals ...
reuters.com/business/healthcare-pharmaceuticals/merck-combination-treatment-lung-cancer-fails-late-stage-study-2024-03-21/
Health Benefits of Rhodiola: Rhodiola offers many health benefits when incorporated into a balanced lifestyle. Learn about how the herb can support mental and ...
health.com/rhodiola-benefits-8606881
Covid-19 anniversary: How have GSK and Astrazeneca fared since?: GSK and Astrazeneca, both played a role in the battle against Covid-19, but how have they fared ...
cityam.com/covid-19-anniversary-how-have-gsk-and-astrazeneca-fared-since/
AstraZeneca Stock Slips on Soft Earnings Report as Cancer Drug Sales Disappoint: The drugmaker AstraZeneca reported underwhelming earnings for its fourth quarter ...
barrons.com/articles/astrazeneca-earnings-stock-price-6ee446ba
Paid articlePaid FTSE 100 retreats as AstraZeneca earnings disappoint
reut.rs/3w8phRj
Quick Glance: First Argentine Saint Unites Pope Francis and Milei
- Argentine Catholics celebrate Pope Francis' 10th anniversary at Basilica de Lujan in Buenos Aires.
- Pope Francis will canonize Maria Antonia de Paz y Figueroa, known as 'Mama Antula'.
- Former critic, Argentine President Javier Milei, will attend the ceremony.
- Milei will also meet Italy's President and Prime Minister after visiting Israel and the Vatican.
COVID Vaccine Maker Sued Over Deaths: AstraZeneca is being taken to court by a group of people who lost loved ones due to a rare adverse reaction to the ...
newsweek.com/covid-vaccine-maker-astrazeneca-sued-over-deaths-1872414
Astrazeneca says Catalent deal shows need for in-house capacity: The sale of listed contract drugmaker Catalent (CTLT.N) to the parent of Novo Nordisk (NOVOb ...
reuters.com/markets/deals/astrazeneca-says-catalent-deal-shows-importance-in-house-capacity-2024-02-08/
UK shares muted on receding rate cut bets; AstraZeneca gains: British equities started the week on a sombre note as fading hopes of interest rate cuts by global ...
reuters.com/world/uk/ftse-100-muted-receding-rate-cut-bets-astrazeneca-gains-2024-02-19/
Astra Zeneca ranked best employer across Africa: AstraZeneca, a leading global pharmaceutical company, has secured the prestigious Top Employer and Best Place to ...
standardmedia.co.ke/health/health-science/article/2001491244/astra-zeneca-ranked-best-employer-across-africa
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
cnbc.com/2024/03/10/pfizer-is-betting-big-on-cancer-drugs-after-covid-decline.html
FDA approves J&J's combination therapy for a type of lung cancer: The U.S. health regulator on Friday approved Johnson & Johnson's therapy in combination with ...
reuters.com/business/healthcare-pharmaceuticals/fda-approves-jnjs-combination-therapy-patients-with-type-lung-cancer-2024-03-01/
Study proposes streamlined approach to developing cancer drugs: Drug discovery can be a frustrating process of trial and error. Scientists using fragment-based ...
medicalxpress.com/news/2024-02-approach-cancer-drugs.html
Mixed Outcomes in European Markets; U.S. Approval Elevates AstraZeneca: On February 19, European stock markets displayed mixed outcomes, halting a three-day gain ...
riotimesonline.com/mixed-outcomes-in-european-markets-u-s-approval-elevates-astrazeneca/
With Moderna and AstraZeneca: This biotech fund has gained over 900% in the last 20 years
boerse-online.de/nachrichten/fonds/mit-moderna-und-astrazeneca-dieser-biotech-fonds-hat-in-den-letzten-20-jahren-ueber-900-zugelegt-20350596.html
AstraZeneca targets 2024 growth but mixed views hit shares: AstraZeneca (AZN.L) expects to boost 2024 revenue and profit on the back of its blockbuster cancer ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-sees-higher-annual-revenue-profit-2024-02-08/
Quick Glance: Netanyahu Rejects Hamas Ceasefire, Pursues Total Victory
- Netanyahu says total victory in Gaza is within reach, rejecting the latest offer from Hamas for a ceasefire to ensure the return of hostages.
- He renews a pledge to destroy the Palestinian Islamist movement, insisting that total victory is the only solution to the Gaza war.
- Hamas had proposed a ceasefire of four-and-a-half months, during which all hostages would go free and Israel would withdraw its troops from the Gaza Strip.
- A Hamas delegation would travel to Cairo on Thursday to pursue ceasefire talks with the mediators Egypt and Qatar.
AstraZeneca Chief Warns Weight Loss Drugs Can Shrink Muscle Mass: Obesity treatments are witnessing a boom in demand, with experts expecting the industry to be ...
indiatimes.com/lifestyle/self/weight-loss-drugs-can-shrink-muscle-mass-627297.html
My father got lung cancer without a puff of smoke: Eliud Kibiwott, 68, didn’t drink or smoke yet he was diagnosed with lung cancer.
nation.africa/kenya/health/my-father-got-lung-cancer-without-a-puff-of-smoke-4514592
AstraZeneca FY23 Earnings Review: It's OK To Buy Dip On Q4 Bottom Line Miss: AstraZeneca reported $45.8bn in revenues for 2023, a 6% gain from the previous year ...
seekingalpha.com/article/4668646-astrazeneca-fy23-earnings-review-its-ok-to-buy-dip-on-q4-bottom-line-miss
Paid articlePaid
Profit up in fourth quarter for Anglo-Swedish pharma AstraZeneca : Anglo-Swedish drug major AstraZeneca reported a profit increase in its fourth quarter of $960 ...
nordot.app/1128286646824632665
5 growth stocks that Wall Street analysts would buy right now: Finding sensible growth stocks for your portfolio is not always easy. But perhaps these five ...
boerse-online.de/nachrichten/aktien/5-wachstumsaktien-die-auch-wall-street-analysten-jetzt-sofort-kaufen-wuerden-20349728.html
Oncology with courage : AstraZeneca has an ambitious vision: to ensure that cancer will no longer be a life-threatening disease in the future ...
diepresse.com/18056704/onkologie-mit-mut
AstraZeneca leaps after smashing first-quarter forecasts: AstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-beats-first-quarter-revenue-profit-estimates-2024-04-25/
Proxy advisers inflict ‘serious harm’ to UK, says AstraZeneca chair : Michel Demaré in FT hits out at ISS and Glass Lewis for applying ‘double standards’ after ...
ft.com/content/838177cd-af87-4b86-ac47-ecfc45665020
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics